These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: A randomized, controlled, double-masked clinical trial. Gonzalez-Salinas R; Karpecki P; Yeu E; Holdbrook M; Baba SN; Ceballos JC; Massaro-Corredor M; Corredor-Ortega C; Ramos-Betancourt N; Quiroz-Mercado H Cont Lens Anterior Eye; 2022 Aug; 45(4):101492. PubMed ID: 34332895 [TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Topical Lotilaner Ophthalmic Solution 0.25% for the Treatment of Gonzalez-Salinas R; Yeu E; Holdbrook M; Baba SN; Ceballos JC; Massaro-Corredor M; Corredor-Ortega C; Ramos-Betancourt N; Quiroz-Mercado H J Ophthalmol; 2021; 2021():3862684. PubMed ID: 34603770 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Yeu E; Holdbrook M; Baba SN; Ceballos JC; Massaro-Corredor M; Corredor-Ortega C; Ramos-Betancourt N; Quiroz-Mercado H; Gonzalez-Salinas R Ocul Immunol Inflamm; 2023 Oct; 31(8):1653-1661. PubMed ID: 35914297 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Meta-Analysis of Randomized Controlled Trials. Muhammad Muneeb Akhtar S; Fareed A; Sohaib Asghar M; Mumtaz M; Kaur S Cont Lens Anterior Eye; 2024 Jun; 47(3):102148. PubMed ID: 38514290 [TBL] [Abstract][Full Text] [Related]
7. Long-Term Outcomes of 6-Week Treatment of Lotilaner Ophthalmic Solution, 0.25%, for Demodex Blepharitis: A Noninterventional Extension Study. Sadri E; Paauw JD; Ciolino JB; Nijm L; Simmons B; Meyer J; Gaddie IB; Berdy GJ; Holdbrook M; Baba SN; Jalalat P; Yeu E Cornea; 2024 Nov; 43(11):1368-1374. PubMed ID: 38334465 [TBL] [Abstract][Full Text] [Related]
8. Xdemvy Gupta AK; Mann A; Vincent K; Abramovits W Skinmed; 2024; 22(1):61-66. PubMed ID: 38494618 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Lotilaner Ophthalmic Solution (0.25%) for the Treatment of Demodex Blepharitis: A GRADE Assessed Systematic Review and Meta-Analysis of Observational & Experimental Studies. Talha M; Haris Ali M; Fatima E; Nadeem A; Ahmed A; Nashwan AJ Am J Ophthalmol; 2024 Aug; 264():8-16. PubMed ID: 38513948 [TBL] [Abstract][Full Text] [Related]
10. Palpebral and facial skin infestation by Demodex folliculorum. Aumond S; Bitton E Cont Lens Anterior Eye; 2020 Apr; 43(2):115-122. PubMed ID: 31563449 [TBL] [Abstract][Full Text] [Related]
11. Role of Topical 5-Fluorouracil in Demodex -Associated Blepharitis. Amer MM; Ho JW; Theotoka D; Wall S; Galor A; Cheng A; Miller D; Karp CL Cornea; 2024 Jun; 43(6):720-725. PubMed ID: 38236070 [TBL] [Abstract][Full Text] [Related]
12. Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1). Yeu E; Wirta DL; Karpecki P; Baba SN; Holdbrook M; Cornea; 2023 Apr; 42(4):435-443. PubMed ID: 35965392 [TBL] [Abstract][Full Text] [Related]
13. Fluorescein dye improves microscopic evaluation and counting of demodex in blepharitis with cylindrical dandruff. Kheirkhah A; Blanco G; Casas V; Tseng SC Cornea; 2007 Jul; 26(6):697-700. PubMed ID: 17592319 [TBL] [Abstract][Full Text] [Related]
14. A Systematic Review and Meta-Analysis of the Safety and Efficacy of 0.25% Lotilaner Ophthalmic Solution in the Treatment of Demodex Blepharitis. Awan B; Elsaigh M; Tariq A; Badee M; Loomba A; Khedr Y; Abdelmaksoud A Cureus; 2024 Jan; 16(1):e52664. PubMed ID: 38380217 [TBL] [Abstract][Full Text] [Related]
15. Novel In-Office Technique for Visual Confirmation of Demodex Infestation in Blepharitic Patients. Man Peles I; Zahavi A; Chemodanova E; Vardizer Y Cornea; 2020 Jul; 39(7):858-861. PubMed ID: 32049679 [TBL] [Abstract][Full Text] [Related]
16. Demodex Blepharitis: A Comprehensive Review of the Disease, Current Management, and Emerging Therapies. Rhee MK; Yeu E; Barnett M; Rapuano CJ; Dhaliwal DK; Nichols KK; Karpecki P; Mah FS; Chan A; Mun J; Gaddie IB Eye Contact Lens; 2023 Aug; 49(8):311-318. PubMed ID: 37272680 [TBL] [Abstract][Full Text] [Related]
17. Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Davey PG; Farid M; Karpecki P; Gaddie IB; Chan A; Mun J; Neervannan S; Yeu E Healthcare (Basel); 2024 Jul; 12(15):. PubMed ID: 39120190 [No Abstract] [Full Text] [Related]
19. Efficacy of Topical Ivermectin 1% in the Treatment of Demodex Blepharitis. Choi Y; Eom Y; Yoon EG; Song JS; Kim IH; Kim HM Cornea; 2022 Apr; 41(4):427-434. PubMed ID: 34173370 [TBL] [Abstract][Full Text] [Related]
20. The effect of lid hygiene on the tear film and ocular surface, and the prevalence of Demodex blepharitis in university students. Murphy O; O' Dwyer V; Lloyd-McKernan A Cont Lens Anterior Eye; 2020 Apr; 43(2):159-168. PubMed ID: 31548151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]